979 related articles for article (PubMed ID: 17002676)
21. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart.
Rohrbach S; Simm A; Pregla R; Franke C; Katschinski DM
Biogerontology; 2005; 6(3):165-71. PubMed ID: 16041620
[TBL] [Abstract][Full Text] [Related]
22. Co-transactivation of the 3' erythropoietin hypoxia inducible enhancer by the HIF-1 protein.
Varma S; Cohen HJ
Blood Cells Mol Dis; 1997 Aug; 23(2):169-76. PubMed ID: 9236155
[TBL] [Abstract][Full Text] [Related]
23. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
24. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
25. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
26. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
Jaakkola PM; Rantanen K
Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539
[TBL] [Abstract][Full Text] [Related]
27. Regulation of erythropoietin production.
Jelkmann W
J Physiol; 2011 Mar; 589(Pt 6):1251-8. PubMed ID: 21078592
[TBL] [Abstract][Full Text] [Related]
28. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
[TBL] [Abstract][Full Text] [Related]
29. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
[TBL] [Abstract][Full Text] [Related]
30. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.
Percy MJ; Zhao Q; Flores A; Harrison C; Lappin TR; Maxwell PH; McMullin MF; Lee FS
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):654-9. PubMed ID: 16407130
[TBL] [Abstract][Full Text] [Related]
31. Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
Takei A; Ekström M; Mammadzada P; Aronsson M; Yu M; Kvanta A; André H
Sci Rep; 2017 Feb; 7():42546. PubMed ID: 28186209
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia and the HIF system in kidney disease.
Nangaku M; Eckardt KU
J Mol Med (Berl); 2007 Dec; 85(12):1325-30. PubMed ID: 18026918
[TBL] [Abstract][Full Text] [Related]
33. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
Kasiganesan H; Sridharan V; Wright G
Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
[TBL] [Abstract][Full Text] [Related]
34. Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor.
Arsenault PR; Song D; Bergkamp M; Ravaschiere AM; Navalsky BE; Lieberman PM; Lee FS
Chembiochem; 2016 Dec; 17(24):2316-2323. PubMed ID: 27770548
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the Hypoxic Response.
Pugh CW
Adv Exp Med Biol; 2016; 903():259-71. PubMed ID: 27343102
[TBL] [Abstract][Full Text] [Related]
36. Role and regulation of prolyl hydroxylase domain proteins.
Fong GH; Takeda K
Cell Death Differ; 2008 Apr; 15(4):635-41. PubMed ID: 18259202
[TBL] [Abstract][Full Text] [Related]
37. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Strowitzki MJ; Cummins EP; Taylor CT
Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia as a target for tissue specific gene therapy.
Rhim T; Lee DY; Lee M
J Control Release; 2013 Dec; 172(2):484-94. PubMed ID: 23742881
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor expression in human RPE cells.
Forooghian F; Razavi R; Timms L
Br J Ophthalmol; 2007 Oct; 91(10):1406-10. PubMed ID: 17567660
[TBL] [Abstract][Full Text] [Related]
40. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]